Zhang, Alexia Y

Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016

Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 198

Burden of Candidemia in the United States, 2017

Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 163

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015

Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society

Antifungal resistance and susceptibilityNeonatal and Maternal Infections

Cited by 81

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017

Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 54

Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021

Jenkins, E. N., Gold, J. A. W., Benedict, K., Lockhart, S. R., Berkow, E. L., Dixon, T., Shack, S. L., Witt, L. S., Harrison, L. H., Seopaul, S., et al. (2025) · MMWR. Surveillance Summaries

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 43

Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018.

Gold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 20

1722. The changing epidemiology of candidemia in the United States: injection drug use as an emerging risk factor for candidemia

Zhang, A. Y., Shrum, S., Williams, S., Vonbank, B., Hillis, S., Barter, D., Petnic, S., Harrison, L. H., Dumyati, G., Phipps, E. C., et al. (2018) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 2